Structural classification of CDR-H3 in antibodies

FEBS Letters
H ShiraiH Nakamura

Abstract

Large varieties in the lengths and the amino acid sequences of the third complementarity determining region of the antibody heavy chain (CDR-H3) have made it difficult to establish a relationship between the sequences and the tertiary structures, in contrast to the other CDRs, which are classified by their canonical structures. A total of 55 CDR-H3 segments from well determined crystal structures were analyzed, and we have derived several remarkable rules, which could partly govern the CDR-H3 conformation dependence on the sequence. Since the rules are physically reasonable, they are expected to be applicable to structural modeling and design of antibodies.

References

May 25, 1977·Journal of Molecular Biology·F C BernsteinM Tasumi
Oct 5, 1992·Journal of Molecular Biology·C ChothiaG Winter
Jan 5, 1991·Journal of Molecular Biology·I S MianA J Olson
Jan 1, 1990·Annual Review of Biochemistry·D R DaviesS Sheriff
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A C MartinA R Rees
Dec 21, 1989·Nature·C ChothiaW R Tulip
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·N C ChienE D Getzoff
Aug 20, 1987·Journal of Molecular Biology·C Chothia, A M Lesk
Nov 15, 1986·The Biochemical Journal·E J Milner-White, R Poet
Nov 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·D M SegalD R Davies
Dec 1, 1994·Current Opinion in Structural Biology·I A Wilson, R L Stanfield
Apr 1, 1995·Protein Engineering·M ReczkoS Suhai
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·A Kidera
Mar 1, 1994·Protein Science : a Publication of the Protein Society·Q ZhengD J Kyle
Oct 15, 1993·Structure·R L StanfieldI A Wilson
Feb 1, 1994·Molecular Immunology·E A Padlan
Jan 21, 1994·Journal of Molecular Biology·V A RobertsE D Getzoff
May 1, 1993·Proteins·T T WuE A Kabat
Mar 1, 1996·Nature Biotechnology·C MandalD S Linthicum

❮ Previous
Next ❯

Citations

Nov 26, 2002·Journal of Molecular Recognition : JMR·Paul A Ramsland, William Farrugia
Jan 29, 2000·Journal of Immunological Methods·L Riechmann, S Muyldermans
Jun 8, 2002·Journal of Molecular Biology·Erica Ollmann SaphireIan A Wilson
Jun 26, 2003·Journal of Molecular Biology·Marcello DoniniEugenio Benvenuto
Jan 22, 1998·Current Opinion in Structural Biology·I A Wilson, K C Garcia
Aug 31, 2001·Journal of Biotechnology·S Muyldermans
Jul 22, 2008·Bioinformatics·Paolo MarcatiliAnna Tramontano
Jun 5, 2012·Protein Engineering, Design & Selection : PEDS·Daisuke KurodaHaruki Nakamura
Jul 5, 2006·Journal of Bioinformatics and Computational Biology·Oleg V KoliasnikovAlexey M Egorov
Jan 16, 2007·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroki Shirai, Masato Kobori
Feb 23, 2011·International Journal of Molecular Sciences·Mattia PedottiLuca Varani
Aug 15, 2014·PloS One·Somdutta SahaThomas Kieber-Emmons
Nov 7, 2014·Nature Protocols·Paolo MarcatiliAnna Tramontano
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D B SmithrudR Hirschmann
Jul 30, 2014·Bioinformatics·Kazuo YamashitaDaron M Standley
Jan 13, 2015·Structure·Brian D WeitznerJeffrey J Gray
May 25, 2011·Molecular Immunology·Thomas J MaliaAlexey Teplyakov
Nov 3, 2010·Journal of Molecular Biology·Benjamin NorthRoland L Dunbrack
Mar 4, 2008·Molecular Immunology·Maria Elena VillaniMarcello Donini
Jan 24, 2007·Journal of Molecular Biology·Masayoshi SakakuraIchio Shimada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.